FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4233657780> ?p ?o ?g. }

• W4233657780 endingPage "A3" @default.
• W4233657780 startingPage "A3" @default.
• W4233657780 abstract "Lepore et al (p. 2212) addressed the question of whether intravitreal bevacizumab is safe over the long term for type 1 retinopathy of prematurity (ROP) and found that pretreatment structural abnormalities were less likely to resolve in eyes treated with intravitreal bevacizumab than in eyes treated with conventional laser photoablation. All 13 infants in this case series had type 1 zone 1 ROP; 1 eye was randomized to receive 0.5 mg bevacizumab, while the fellow eye was treated with laser. Twenty-three eyes completed the study. At 9 months, macular abnormalities were still evident in 9 of the 12 bevacizumab eyes (75%) and in 4 of the 11 lased eyes (36.4%), while capillary bed loss was noted in 11 of the bevacizumab eyes (91.6%) and 3 of the lased eyes (27.3%). Similarly, branching abnormalities (tangles) were present in 11 of the bevacizumab eyes (91.6%), vs. 3 of the lased eyes (27.3%). The results argue for erring on the side of caution, the researchers concluded. In a systematic review and meta-analysis, Tham et al (p. 2081) examined the global prevalence of primary open-angle glaucoma (POAG) and primary angle-closure glaucoma (PACG) and projected the number of persons likely to be affected in 2020 and 2040. In 2013, 64.3 million persons (aged 40 to 80 years) worldwide had glaucoma, for a global prevalence rate of 3.54%. The total number of cases can be expected to increase to 76 million in 2020 and to 111.8 million in 2040, with the disease burden continuing to fall disproportionately on people living in Africa and Asia (in 2013, Asia had 60% of all cases of glaucoma, and Africa had 13% of all cases). With regard to POAG and PACG, the prevalence of POAG is highest in Africa (4.2%), while the prevalence of PACG is highest in Asia (1.09%). Srikumaran et al (p. 2159) evaluated long-term outcomes with the Boston Type 1 Keratoprosthesis (KPro) and found that half of patients were able to achieve and retain vision of 20/200 or better. This retrospective series analyzed outcomes for 139 eyes of 133 patients. Mean follow-up was 46.7±26 months (range, 6 weeks to 8.7 years). Slightly more than half (52.5%) of eyes had more than 4 years of follow-up, and 15 eyes (19.95%) had 7 years of follow-up. Preoperatively, only 10.8% of eyes were 20/200 or better; postoperatively, this rose to 70% and then leveled off at 50% of eyes at the last follow-up visit. The overall probability of retention was 84% at 2 years and 67% at 7 years. The cumulative incidence of complications was 49.7% for retroprosthetic membrane formation, 21.6% for glaucoma surgery, 18.6% for retinal detachment, and 15.5% for endophthalmitis. As these complications can occur long after initial surgery, continued close follow-up is essential, the researchers said. Open-globe injuries in combat soldiers are a well-documented phenomenon and are usually detected early during triage. But what about closed-globe injuries, which may coexist with normal or near-normal vision? Cockerham et al (p. 2165) evaluated closed-globe conjunctival and corneal injuries and endothelial cell abnormalities in a 65 blast-exposed veterans with traumatic brain injury (TBI). The researchers found that 16 (25%) of the veterans, who were examined 2 weeks after blast exposure, had ocular surface trauma in zone 1 without full-thickness penetration or compromise of the eye wall. Injuries included corneal scars, Descemet membrane ruptures, and embedded metallic foreign bodies. In addition, affected eyes were more likely to have endothelial cell abnormalities. These injuries occurred independently of TBI severity or the use of protective eyewear. The researchers noted that this study is the first to document Descemet membrane ruptures from blast exposure, and they recommended that all combat soldiers with TBI undergo a thorough ophthalmic examination for blast injuries (see Figure on page 2168)." @default.
• W4233657780 created "2022-05-12" @default.
• W4233657780 creator A5046285193 @default.
• W4233657780 creator A5075420045 @default.
• W4233657780 date "2014-11-01" @default.
• W4233657780 modified "2023-09-25" @default.
• W4233657780 title "This Issue At A Glance" @default.
• W4233657780 doi "https://doi.org/10.1016/j.ophtha.2014.09.019" @default.
• W4233657780 hasPublicationYear "2014" @default.
• W4233657780 type Work @default.
• W4233657780 citedByCount "0" @default.
• W4233657780 crossrefType "journal-article" @default.
• W4233657780 hasAuthorship W4233657780A5046285193 @default.
• W4233657780 hasAuthorship W4233657780A5075420045 @default.
• W4233657780 hasBestOaLocation W42336577801 @default.
• W4233657780 hasConcept C118487528 @default.
• W4233657780 hasConcept C141071460 @default.
• W4233657780 hasConcept C2776694085 @default.
• W4233657780 hasConcept C2777802072 @default.
• W4233657780 hasConcept C2778376644 @default.
• W4233657780 hasConcept C2778527774 @default.
• W4233657780 hasConcept C2779234561 @default.
• W4233657780 hasConcept C2779918416 @default.
• W4233657780 hasConcept C54355233 @default.
• W4233657780 hasConcept C71924100 @default.
• W4233657780 hasConcept C86803240 @default.
• W4233657780 hasConceptScore W4233657780C118487528 @default.
• W4233657780 hasConceptScore W4233657780C141071460 @default.
• W4233657780 hasConceptScore W4233657780C2776694085 @default.
• W4233657780 hasConceptScore W4233657780C2777802072 @default.
• W4233657780 hasConceptScore W4233657780C2778376644 @default.
• W4233657780 hasConceptScore W4233657780C2778527774 @default.
• W4233657780 hasConceptScore W4233657780C2779234561 @default.
• W4233657780 hasConceptScore W4233657780C2779918416 @default.
• W4233657780 hasConceptScore W4233657780C54355233 @default.
• W4233657780 hasConceptScore W4233657780C71924100 @default.
• W4233657780 hasConceptScore W4233657780C86803240 @default.
• W4233657780 hasIssue "11" @default.
• W4233657780 hasLocation W42336577801 @default.
• W4233657780 hasOpenAccess W4233657780 @default.
• W4233657780 hasPrimaryLocation W42336577801 @default.
• W4233657780 hasRelatedWork W1969249427 @default.
• W4233657780 hasRelatedWork W2083293189 @default.
• W4233657780 hasRelatedWork W2502072298 @default.
• W4233657780 hasRelatedWork W2891187125 @default.
• W4233657780 hasRelatedWork W3029407746 @default.
• W4233657780 hasRelatedWork W3030040057 @default.
• W4233657780 hasRelatedWork W4200164386 @default.
• W4233657780 hasRelatedWork W4298701792 @default.
• W4233657780 hasRelatedWork W4313154479 @default.
• W4233657780 hasRelatedWork W948362459 @default.
• W4233657780 hasVolume "121" @default.
• W4233657780 isParatext "false" @default.
• W4233657780 isRetracted "false" @default.
• W4233657780 workType "article" @default.